scholarly journals Basal and stimulation day 5 anti-Müllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist–gonadotropin treatment

2005 ◽  
Vol 20 (4) ◽  
pp. 915-922 ◽  
Author(s):  
Joana Peñarrubia ◽  
Francisco Fábregues ◽  
Dolors Manau ◽  
Montserrat Creus ◽  
Gemma Casals ◽  
...  
Keyword(s):  
Assisted Reproductive Technology ◽  
Ovarian Response ◽  
Reproductive Technology ◽  
Gonadotropin Releasing Hormone ◽  
Serum Concentrations ◽  
Releasing Hormone ◽  
Gonadotropin Releasing Hormone Agonist ◽  
Technology Cycles

scholarly journals Luteal-phase support in assisted reproductive technology: An ongoing challenge

2021 ◽  
pp. 761-772
Author(s):  
Saeideh Dashti ◽  
Maryam Eftekhar
Keyword(s):  
In Vitro Fertilization ◽  
Assisted Reproductive Technology ◽  
Luteal Phase ◽  
Reproductive Technology ◽  
Gonadotropin Releasing Hormone ◽  
Vitro Fertilization ◽  
Releasing Hormone ◽  
Luteal Phase Support ◽  
Gonadotropin Releasing Hormone Agonist

It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles. These approaches include progesterone supplements, human chorionic gonadotropin, estradiol, gonadotropin-releasing hormone agonist, and recombinant luteinizing hormone. The main challenge is luteal-phase support (LPS) in cycles with gonadotropin-releasing hormone agonist triggering. There is still controversy about the optimal component and time for starting LPS in assisted reproductive technology cycles. This review aims to summarize the various protocols suggested for LPS in in vitro fertilization cycles. Key words: Luteal-phase support, IVF, HCG, Progesterone, GnRH agonist, Recombinant LH.

Sign in / Sign up

Export Citation Format

Share Document